Navigating FDA-Registered Stem Cell Clinical Trials in the United States
The stem cell therapy landscape in the U.S. is sharply divided between legitimate, FDA-registered clinical trials at academic medical centers and a growing number of unregulated clinics offering unapproved treatments. As of late 2025, the FDA has approved 46 cell and gene therapy products, while over 800 institutions are conducting stem cell-related clinical trials registered on ClinicalTrials.gov.
What "FDA-Approved" Actually Means
The FDA does not approve clinics — it approves products and authorizes clinical trials through Investigational New Drug (IND) applications. Currently approved stem cell products are primarily hematopoietic stem cell transplants (from bone marrow, peripheral blood, or cord blood) and newer CAR-T cell therapies for blood cancers. In December 2024, Ryoncil became the first mesenchymal stem cell (MSC) therapy to receive FDA approval, for pediatric steroid-refractory acute graft-versus-host disease.
Key Therapeutic Areas Under Investigation
- Oncology & Hematology
- HSCT and CAR-T therapies for leukemia, lymphoma, and myeloma remain the largest category, with centers like MD Anderson, City of Hope (20,000+ transplants performed), and Memorial Sloan Kettering leading enrollment.
- Neurology
- iPSC-derived therapies for Parkinson's disease, ALS, and spinal cord injury are advancing rapidly. In 2025, XellSmart received IND clearance for three separate iPSC-based therapies targeting these conditions.
- Ophthalmology
- Pluripotent stem cell-derived retinal therapies represent one of the fastest-growing trial categories, with over 115 global PSC trials as of December 2024.
- Cardiac & Regenerative
- Mayo Clinic's FDA-cleared automated bioreactor platform enables scaled production of bone marrow-derived stem cells for cardiac repair trials.
How to Verify a Clinic's Legitimacy
The FDA's Consumer Alert on Regenerative Medicine warns patients to verify any stem cell treatment through these steps:
- Confirm the trial is registered on ClinicalTrials.gov with a valid NCT number
- Verify the institution holds an active IND application with the FDA
- Check that the clinic is affiliated with an accredited academic medical center or recognized by the National Marrow Donor Program (NMDP)
- Be wary of clinics charging patients to participate in "clinical trials" — legitimate trials typically cover treatment costs